Evidence map›Paper›PMID 42647237›Full record

ReviewPathophysiology : the official journal of the International Society for Pathophysiology2026

A Comprehensive Meta-Analysis of the Cardiovascular Adverse Effects of Bispecific Antibody Therapy in Hematologic Malignancies.

Derek Tai, Navneet Sandhu, Aren Dermarderosian, Norayr Mkrtchyan, Daniel Park, Vinisha Garg, Angel Nguyen, Mojtaba Akhtari

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pathophysiology : the official journal of the International Society for Pathophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Derek TaiDepartment of Medicine, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.ORCID 0000-0002-6461-5560
Navneet SandhuDepartment of Medicine, University California San Francisco Fresno, Fresno, CA 93701, USA.
Aren DermarderosianDepartment of Chemistry and Biochemistry, University of California Los Angeles, Los Angeles, CA 90095, USA.ORCID 0009-0001-9038-8752
Norayr MkrtchyanSchool of Medicine, University of California Davis, Sacramento, CA 95817, USA.
Daniel ParkDepartment of Hematology/Oncology, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Vinisha GargDepartment of Cardiology, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
Angel NguyenSkaggs School of Pharmacy and Pharmaceutical Science, University of California, La Jolla, San Diego, CA 92093, USA.
Mojtaba AkhtariDivision of Transplant, Cellular Therapy and Hematologic Malignancies, Loma Linda University Cancer Center, 11234 Anderson St, Loma Linda, CA 92354, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bispecific antibodiescardio-oncologycardiotoxicitycardiovascular adverse eventsmalignant hematology

Identifiers

PMID42647237
PMCPMC13510379

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.